ELAN
$22.14+1.70%
as of close, Oct 2, 2026
☾ AH $22.14 +1.70%
Elanco Animal Health IncorporatedStock · Health CareRussell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%
ELAN — Elanco Animal Health Incorporated price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
10.015.020.025.030.035.00100.0M$22.14—20182020202220242026
2026-10-02
Price$22.14
MA20$23.71
MA50$23.33
Vol21.6M
Key stats
Price data
- Price
- $22.14
- Change YTD
- -2.17%
- Next earnings
- Nov 6, 2026 · Before open
- Market cap
- 11.1B
- Enterprise value
- 14.6B
- Shares outstanding
- 499.6M
- 52W low
- $19.40
- 52W high
- $27.98
- From 52W high
- -20.87%
- From 52W low
- +14.12%
- 52W range
- 32%
- Beta
- 1.67
Volume
- Rel volume
- 0.94×
- 30D volume
- 5.3M
- 30D $ vol
- 123.9M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- +$1.5M
- Insider net 1Y
- +$1.7M
Form 4 transactions by trade date, as filed; latest on file 2026-08-20.
Fundamentals
- Sales (ttm)
- 5B
- Sales/share
- $10.05
- EPS (ttm)
- -$0.40
- FCF (ttm)
- 379M
- FCF/share
- $0.76
- Book value/share
- $13.19
- Net margin
- -3.96%
- ROE
- -3.02%
- ROA
- -1.47%
- Debt / equity
- 0.56×
- Current ratio
- 2.05
Growth (CAGR, ttm) · 10Y
- Sales
- +11.96%+5.09%+1.99%+5.90%
- FCF
- +4.99%n/an/a+24.99%
- Shares
- +0.57%+0.47%+1.10%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +11.33%+4.60%+0.88%n/a
- FCF/share
- +4.40%n/an/an/a
- Book value/share
- -3.31%-4.33%-4.81%n/a
- Price
- +8.16%+26.41%-7.15%n/a
- Total return
- +8.16%+26.41%-7.15%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -55.4×
- Fwd P/E
- 17.3×
- P/S (ttm)
- 2.2×
- P/B (mrq)
- 1.7×
- P/FCF (ttm)
- 29.2×
- EV/Sales (ttm)
- 2.9×
- FCF yield (ttm)
- 3.43%
- Buyback yield (realized, 1y)
- -0.57%
- Shareholder yield (realized, 1y)
- -0.57%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 42nd
- P/B
- 57th
- P/FCF
- 38th
Bar = where today’s multiple sits in ELAN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-02
1D
+1.70%
5D
-0.76%
1M
-10.29%
3M
-11.44%
YTD
-2.17%
1Y
+8.16%
5Y
-31.01%
Recent filings
- Aug 20Insider buy · Kurzius Lawrence Erik (Director) bought 40,000 shares for $936K at $23.40
- Aug 18Insider buy · O'Neill Shiv (GC AND CORP SEC) bought 3,998 shares for $94K at $23.58
- Aug 12Insider buy · Harrington Michael J (Director) bought 5,000 shares for $109K at $21.82
- Aug 7Insider buy · Herendeen Paul (Director) bought 10,000 shares for $237K at $23.69
- Aug 7Insider buy · VanHimbergen Robert M (EVP and CFO) bought 4,200 shares for $97K at $23.08
Financial statements
Open full ELAN financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -13.21% | -0.04% |
| NVO | Novo Nordisk A/S | -20.21% | -0.21% |
| SNY | Sanofi ADS | -10.23% | -1.84% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.76% | -0.32% |
| NTRA | Natera Inc. | +26.20% | +0.46% |
| ARGX | argenx SE American Depositary Shares | -12.90% | -1.79% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.09% | +0.00% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +5.44% | +0.56% |
